Literature DB >> 4927759

3-O-methyldopa, a new precursor of dopamine.

G Bartholini, I Kuruma, A Pletscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4927759     DOI： 10.1038/230533a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  17 in total

1.  Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease.

Authors:  M Yamamoto; M Yokochi; S Kuno; Y Hattori; Y Tsukamoto; H Narabayashi; H Tohgi; Y Mizuno; H Kowa; N Yanagisawa; I Kanazawa
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 3.  Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors:  D B Calne; J L Reid
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Formation of dopamine from 3-methoxytyrosine. Fact or artifact?

Authors:  A Carlsson; B Waldeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Demethylation of L-3-methoxytyrosine in vivo.

Authors:  G Bartholini; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Behavioral and biochemical effects of alpha-methyltyrosine in cats.

Authors:  A Kitsikis; A G Roberge
Journal:  Psychopharmacologia       Date:  1973-07-17

7.  Effect of L-dopa on delayed response and visual discrimination in cats and its relation to brain chemistry.

Authors:  A Kitsikis; A G Roberge; G Frenette
Journal:  Exp Brain Res       Date:  1972       Impact factor: 1.972

8.  L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.

Authors:  L Davidson; K Lloyd; J Dankova; O Hornykiewicz
Journal:  Experientia       Date:  1971-09-15

9.  Demethylation of 3-O-methyldopa.

Authors:  J P Chalmers; D S Davies; G H Draffan; J L Reid; S S Thorgeirsson
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

10.  Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.

Authors:  F S Messiha; T H Hsu; J R Bianchine
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.